日本における第2世代抗ヒスタミン薬のエビデンス

書誌事項

タイトル別名
  • Evidence of anti-histamine for allergic rhinitis in Japan

この論文をさがす

説明

Anti-histamine evidence level in the allergic rhinitis treatment of Japan was not high. It is because in addition, there is not making in English public of it is hardly and not the use of the placebo to it by the examination from which only the development clinical trial is made randomized. Recently, after it is marketed, a lot of evidences are collected, and therefore, the result is made public in English, and the level has improved to the development clinical trial. As for the treatment strategy of the allergic rhinitis, the effect assumes the sneezing and the rhinorrhea type to be the adjustment for anti-histamine, and using with high effect and low side effect one on an actual clinical site as described in the guideline. On the other hand, it is necessary to prescribe LTRA and the steroid drug chiefly in the blockage type. It exists with a personal variation in the effect, it is necessary to know the anti-histamine cannot be selected only by compared agents though the effect of various ant-histamine is examined by the field examination and the exposure test, etc.<br>

収録刊行物

参考文献 (18)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ